AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edarakal 20mg Injection

Prescription Icon
Prescription Required

Marketer

Kalmia Healthcare

Salt Composition

Edaravone (20mg)

Overview Edarakal 20mg Injection

For individuals with amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular condition, Edarakal 20mg Injection offers therapeutic intervention. This antioxidant medication mitigates nerve cell deterioration, thus potentially slowing disease advancement. Administered intravenously by a qualified healthcare provider, this injectable formulation is reserved for patients unable to tolerate oral medication. Dosage and treatment duration should strictly adhere to physician instructions. Missed doses should be taken upon recollection. Commonly reported adverse effects include headache, ecchymosis, and gait abnormalities. Transient injection site reactions (pain, erythema, edema) may occur but typically resolve spontaneously. Persistent or bothersome side effects warrant immediate medical consultation. Seek immediate medical assistance if allergic reactions—such as pruritus, lip/tongue/facial swelling—develop.

Uses of Edarakal 20mg Injection

Lou Gehrig's disease

Major Benefits of Edarakal 20mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Edarakal 20mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edarakal 20mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Edarakal 20mg Injection works:

Edarakal 20mg Injection offers antioxidant, neuroprotective, and nootropic benefits. Its mechanism involves mitigating nerve damage from free radical attack, thus slowing ALS symptom progression. This action is achieved by counteracting oxidative stress within the brain, restoring a balance between antioxidants and harmful free radicals.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edarakal 20mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Edarakal 20mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Edarakal 20mg Injection while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Edarakal 20mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Edarakal 20mg Injection to individuals with renal impairment. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Edarakal 20mg Injection cautiously, potentially requiring dose modification. Consult a physician for guidance. Data regarding Edarakal 20mg Injection use in such patients is limited. Dose alteration isn't advised for those with mild or moderate liver dysfunction.

What if you forget to take Edarakal 20mg Injection :

NA

Facts to Know About Edarakal 20mg Injection

LabelValue
Chemical Type Pyrazolone Derivatives
Developing Habits No.
Type of Treatment Neuroscience (Central Nervous System)
Actions Cognitive enhancer

FAQs on Edarakal 20mg Injection

Edarakal 20mg Injection may commonly cause confusion, headache, and gait disturbances. Less frequent side effects include skin rash and itching, shortness of breath, chest tightness, wheezing, cough (particularly in asthmatics), and fungal infections.
Administered intravenously by a healthcare professional, Edarakal 20mg Injection is a solution given over one hour in a medical setting. The typical dosage during the initial 28-day cycle involves daily injections for the first 14 days; subsequent cycles usually consist of daily injections for the first 10 days. Dosage frequency is determined by your doctor based on your individual response.
Edarakal 20mg Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to nerve cell death. It works by slowing the progression of ALS-related nerve damage.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Edarakal 20mg Injection ingredient. Before taking Edarakal, inform your doctor about all other medications, vitamins, and supplements you're using or plan to use; dose adjustments or close monitoring may be needed. Also, tell your doctor if you have asthma, are pregnant or breastfeeding, or plan to become pregnant. Contact your doctor immediately if you conceive while using edaravone.
While the preventability of ALS remains unproven due to a lack of supporting studies, reducing exposure to certain risk factors may lower the likelihood of developing the disease. These factors include smoking, and exposure to pesticides and insecticides. Military service has also been identified as a potential risk factor.
People of Caucasian and non-Hispanic descent have the highest incidence of ALS. Between 5% and 10% of ALS cases are familial, inherited from parents. Onset can occur at any age, though most commonly between ages 55 and 75. Men are slightly more prone than women, but this difference diminishes with age. Research indicates military veterans may have a 1.5 to 2 times greater risk due to potential wartime toxin exposure.
Exposure to toxins from warfare or intense physical exertion may heighten the risk of ALS in veterans and athletes, researchers propose.
ALS often begins with subtle muscle problems: twitching in limbs or tongue, cramps, stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and swallowing difficult. A common first sign is hand or arm weakness, hindering tasks like buttoning a shirt or turning a key. Alternatively, leg weakness may be the initial symptom, manifesting as clumsiness while walking, increased tripping, or stumbling.
Edarakal 20mg Injection
685
MRP 834
17% off